Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | A-443654 |
Synonyms | |
Therapy Description |
A-443654 is a pan-AKT inhibitor, which may inhibit proliferation and promote apoptosis in cancer cells (PMID: 19208828, PMID: 28476032). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
A-443654 | Akt Inhibitor (Pan) 21 | A-443654 is a pan-AKT inhibitor, which may inhibit proliferation and promote apoptosis in cancer cells (PMID: 19208828, PMID: 28476032). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PIK3CA mutant | Advanced Solid Tumor | sensitive | A-443654 | Preclinical | Actionable | In a preclinical study, cells expressing mutant PIK3CA demonstrated increased sensitivity to A-443654 compared to cells expressing wild-type PIK3CA (PMID: 19208828). | 19208828 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|